Published in J Exp Med on February 01, 1992
Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity. J Virol (1995) 7.57
Pathogenesis of human immunodeficiency virus infection. Microbiol Rev (1993) 5.88
Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death. J Exp Med (1995) 4.88
The human immunodeficiency virus type 1 vpr gene arrests infected T cells in the G2 + M phase of the cell cycle. J Virol (1995) 4.42
Fas ligand mediates activation-induced cell death in human T lymphocytes. J Exp Med (1995) 4.34
Reduction in mitochondrial potential constitutes an early irreversible step of programmed lymphocyte death in vivo. J Exp Med (1995) 4.20
Determination of antigen-specific memory/effector CD4+ T cell frequencies by flow cytometry: evidence for a novel, antigen-specific homeostatic mechanism in HIV-associated immunodeficiency. J Clin Invest (1997) 4.01
Regulation of apoptosis by viral gene products. J Virol (1997) 3.67
Critical loss of the balance between Th17 and T regulatory cell populations in pathogenic SIV infection. PLoS Pathog (2009) 3.35
Altered T cell activation and development in transgenic mice expressing the HIV-1 nef gene. EMBO J (1993) 3.13
Contribution of immune activation to the pathogenesis and transmission of human immunodeficiency virus type 1 infection. Clin Microbiol Rev (2001) 2.87
Human immunodeficiency virus infection of the human thymus and disruption of the thymic microenvironment in the SCID-hu mouse. J Exp Med (1993) 2.81
Kinetics of CD4+ T cell repopulation of lymphoid tissues after treatment of HIV-1 infection. Proc Natl Acad Sci U S A (1998) 2.39
Fas antigen stimulation induces marked apoptosis of T lymphocytes in human immunodeficiency virus-infected individuals. J Exp Med (1995) 2.28
The adenovirus death protein (E3-11.6K) is required at very late stages of infection for efficient cell lysis and release of adenovirus from infected cells. J Virol (1996) 2.25
HIV-1 immunopathogenesis: how good interferon turns bad. Clin Immunol (2006) 2.23
Programmed cell death and AIDS: significance of T-cell apoptosis in pathogenic and nonpathogenic primate lentiviral infections. Proc Natl Acad Sci U S A (1994) 2.21
CD4+ T-cell death induced by infectious and noninfectious HIV-1: role of type 1 interferon-dependent, TRAIL/DR5-mediated apoptosis. Blood (2005) 2.21
Retracted HIV-specific cytotoxic T lymphocytes traffic to lymph nodes and localize at sites of HIV replication and cell death. J Clin Invest (2000) 2.17
Reduction of otherwise remarkably stable virus-specific cytotoxic T lymphocyte memory by heterologous viral infections. J Exp Med (1996) 2.14
Upregulation of Fas ligand expression by human immunodeficiency virus in human macrophages mediates apoptosis of uninfected T lymphocytes. J Virol (1996) 2.07
Inhibition of human immunodeficiency virus type 1 replication by SDZ NIM 811, a nonimmunosuppressive cyclosporine analog. Antimicrob Agents Chemother (1994) 1.98
MicroRNA profile changes in human immunodeficiency virus type 1 (HIV-1) seropositive individuals. Retrovirology (2008) 1.96
Rapid-high, syncytium-inducing isolates of human immunodeficiency virus type 1 induce cytopathicity in the human thymus of the SCID-hu mouse. J Virol (1994) 1.87
Regulated expression of human CD4 rescues helper T cell development in mice lacking expression of endogenous CD4. EMBO J (1993) 1.86
Programmed cell death of T lymphocytes during acute viral infection: a mechanism for virus-induced immune deficiency. J Virol (1993) 1.85
The Fas protein is expressed at high levels on CD4+CD8+ thymocytes and activated mature lymphocytes in normal mice but not in the lupus-prone strain, MRL lpr/lpr. Proc Natl Acad Sci U S A (1993) 1.76
CD28 is associated with and induces the immediate tyrosine phosphorylation and activation of the Tec family kinase ITK/EMT in the human Jurkat leukemic T-cell line. Proc Natl Acad Sci U S A (1994) 1.70
Inhibition of apoptosis in human immunodeficiency virus-infected cells enhances virus production and facilitates persistent infection. J Virol (1995) 1.70
HIV-1 directly kills CD4+ T cells by a Fas-independent mechanism. J Exp Med (1998) 1.66
Lens epithelial cell apoptosis appears to be a common cellular basis for non-congenital cataract development in humans and animals. J Cell Biol (1995) 1.64
Macrophage-dependent apoptosis of CD4+ T lymphocytes from HIV-infected individuals is mediated by FasL and tumor necrosis factor. J Exp Med (1997) 1.63
Variants from the diverse virus population identified at seroconversion of a clade A human immunodeficiency virus type 1-infected woman have distinct biological properties. J Virol (1999) 1.61
Interleukin-10 promotes activation-induced cell death of SLE lymphocytes mediated by Fas ligand. J Clin Invest (1997) 1.58
Differential CD4+ T-lymphocyte apoptosis and bystander T-cell activation in rhesus macaques and sooty mangabeys during acute simian immunodeficiency virus infection. J Virol (2008) 1.56
Type 1/type 2 cytokine modulation of T-cell programmed cell death as a model for human immunodeficiency virus pathogenesis. Proc Natl Acad Sci U S A (1994) 1.53
Evasion of cytotoxic T lymphocyte (CTL) responses by nef-dependent induction of Fas ligand (CD95L) expression on simian immunodeficiency virus-infected cells. J Exp Med (1997) 1.52
Intravenous immunoglobulin contains specific antibodies inhibitory to activation of T cells by staphylococcal toxin superantigens [see comment]. J Clin Invest (1993) 1.51
Plasmodium falciparum induces apoptosis in human mononuclear cells. Infect Immun (1996) 1.50
Protease inhibitors selectively block T cell receptor-triggered programmed cell death in a murine T cell hybridoma and activated peripheral T cells. J Exp Med (1993) 1.49
Lymphocyte apoptosis during the silencing of the immune response to acute viral infections in normal, lpr, and Bcl-2-transgenic mice. Am J Pathol (1995) 1.48
Cell-based chemical genetic screen identifies damnacanthal as an inhibitor of HIV-1 Vpr induced cell death. Biochem Biophys Res Commun (2006) 1.48
Infection with human immunodeficiency virus type 1 upregulates DNA methyltransferase, resulting in de novo methylation of the gamma interferon (IFN-gamma) promoter and subsequent downregulation of IFN-gamma production. Mol Cell Biol (1998) 1.48
Human immunodeficiency virus type 1 protease cleaves procaspase 8 in vivo. J Virol (2007) 1.45
Fas and activation-induced Fas ligand mediate apoptosis of T cell hybridomas: inhibition of Fas ligand expression by retinoic acid and glucocorticoids. J Exp Med (1995) 1.45
The significance of shed membrane particles during programmed cell death in vitro, and in vivo, in HIV-1 infection. J Clin Invest (1997) 1.43
Critical contribution of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) to apoptosis of human CD4+ T cells in HIV-1-infected hu-PBL-NOD-SCID mice. J Exp Med (2001) 1.42
The apoptosis-1/Fas protein in human systemic lupus erythematosus. J Clin Invest (1994) 1.37
In vivo analysis of Fas/FasL interactions in HIV-infected patients. J Clin Invest (1998) 1.36
Programmed death of T cells in human immunodeficiency virus infection. No correlation with progression to disease. J Clin Invest (1994) 1.36
CXCR4 and CD4 mediate a rapid CD95-independent cell death in CD4(+) T cells. Proc Natl Acad Sci U S A (1998) 1.35
Macrophage signaling in HIV-1 infection. Retrovirology (2010) 1.35
The human immunodeficiency virus type 1 (HIV-1) CD4 receptor and its central role in promotion of HIV-1 infection. Microbiol Rev (1995) 1.34
Apoptotic regulation of T cells and absence of immune deficiency in virus-infected gamma interferon receptor knockout mice. J Virol (1998) 1.32
Distinct mechanisms trigger apoptosis in human immunodeficiency virus type 1-infected and in uninfected bystander T lymphocytes. J Virol (1998) 1.29
Rapid and irreversible CD4+ T-cell depletion induced by the highly pathogenic simian/human immunodeficiency virus SHIV(DH12R) is systemic and synchronous. J Virol (2002) 1.27
Monocytes treated with human immunodeficiency virus Tat kill uninfected CD4(+) cells by a tumor necrosis factor-related apoptosis-induced ligand-mediated mechanism. J Virol (2003) 1.25
Apoptotic depletion of CD4+ T cells in idiopathic CD4+ T lymphocytopenia. J Clin Invest (1996) 1.25
Human immunodeficiency virus type 1 induces apoptosis in CD4(+) but not in CD8(+) T cells in ex vivo-infected human lymphoid tissue. J Virol (2000) 1.23
HIV-1 envelope induces activation of caspase-3 and cleavage of focal adhesion kinase in primary human CD4(+) T cells. Proc Natl Acad Sci U S A (2000) 1.22
Circulating monocytes in HIV-1-infected viremic subjects exhibit an antiapoptosis gene signature and virus- and host-mediated apoptosis resistance. J Immunol (2009) 1.20
The specific recognition by macrophages of CD8+,CD45RO+ T cells undergoing apoptosis: a mechanism for T cell clearance during resolution of viral infections. J Exp Med (1994) 1.20
HIV-1 accessory protein Vpr: relevance in the pathogenesis of HIV and potential for therapeutic intervention. Retrovirology (2011) 1.17
Human clusterin gene expression is confined to surviving cells during in vitro programmed cell death. J Clin Invest (1994) 1.16
Rapid induction of apoptosis by cell-to-cell transmission of human immunodeficiency virus type 1. J Virol (1995) 1.15
Priming of human CD4+ antigen-specific T cells to undergo apoptosis by HIV-infected monocytes. A two-step mechanism involving the gp120 molecule. J Clin Invest (1997) 1.14
HIV-1 infection impairs cell cycle progression of CD4(+) T cells without affecting early activation responses. J Clin Invest (2001) 1.13
Envelope glycoproteins of human immunodeficiency virus type 1: profound influences on immune functions. Microbiol Rev (1996) 1.13
Dual-Affinity Re-Targeting proteins direct T cell-mediated cytolysis of latently HIV-infected cells. J Clin Invest (2015) 1.13
Bystander sensitization to activation-induced cell death as a mechanism of virus-induced immune suppression. J Virol (2000) 1.13
Role of EGR-1 in thapsigargin-inducible apoptosis in the melanoma cell line A375-C6. Mol Cell Biol (1995) 1.13
Differential requirements for HIV-1 replication in naive and memory CD4 T cells from asymptomatic HIV-1 seropositive carriers and AIDS patients. Clin Exp Immunol (1993) 1.13
Cytopathic killing of peripheral blood CD4(+) T lymphocytes by human immunodeficiency virus type 1 appears necrotic rather than apoptotic and does not require env. J Virol (2002) 1.12
Death of CD4(+) T-cell lines caused by human immunodeficiency virus type 1 does not depend on caspases or apoptosis. J Virol (2002) 1.12
Interleukin 7 reduces the levels of spontaneous apoptosis in CD4+ and CD8+ T cells from HIV-1-infected individuals. Proc Natl Acad Sci U S A (2007) 1.12
Differential susceptibility of naive and memory CD4+ T cells to the cytopathic effects of infection with human immunodeficiency virus type 1 strain LAI. J Virol (1997) 1.11
Neurovirulent simian immunodeficiency virus infection induces neuronal, endothelial, and glial apoptosis. Mol Med (1996) 1.09
High viral burden and rapid CD4+ cell depletion in human immunodeficiency virus type 1-infected SCID-hu mice suggest direct viral killing of thymocytes in vivo. J Virol (1997) 1.09
Differential ability of T cell subsets to undergo activation-induced cell death. Proc Natl Acad Sci U S A (1997) 1.08
CD28: a signalling perspective. Biochem J (1996) 1.08
Pronounced acute immunosuppression in vivo mediated by HIV Tat challenge. Proc Natl Acad Sci U S A (1999) 1.08
Analysis of the T-cell receptor beta-chain variable-region (V beta) repertoire in monozygotic twins discordant for human immunodeficiency virus: evidence for perturbations of specific V beta segments in CD4+ T cells of the virus-positive twins. Proc Natl Acad Sci U S A (1994) 1.07
Lung lymphocyte elimination by apoptosis in the murine response to intratracheal particulate antigen. J Clin Invest (1997) 1.05
The role of virus-induced regulatory T cells in immunopathology. Springer Semin Immunopathol (2006) 1.05
Differential expression of interleukin-2 and gamma interferon in human immunodeficiency virus disease. J Virol (2001) 1.04
Enhanced expression of CTLA-4 (CD152) on CD4+ T cells in HIV infection. Clin Exp Immunol (1999) 1.04
T-cell activation influences initial DNA synthesis of simian immunodeficiency virus in resting T lymphocytes from macaques. J Virol (1993) 1.03
Monocytes are required to prime peripheral blood T cells to undergo apoptosis. Proc Natl Acad Sci U S A (1995) 1.03
Role of the Fas/FasL pathway in HIV or SIV disease. Retrovirology (2009) 1.02
Two subpopulations of human triple-negative thymic cells are susceptible to infection by human immunodeficiency virus type 1 in vitro. J Virol (1994) 1.01
Induction of T-cell apoptosis by human herpesvirus 6. J Virol (1997) 1.01
Tat-induced FOXO3a is a key mediator of apoptosis in HIV-1-infected human CD4+ T lymphocytes. J Immunol (2008) 1.00
CD4+ blood lymphocytes are rapidly killed in vitro by contact with autologous human immunodeficiency virus-infected cells. Proc Natl Acad Sci U S A (1995) 0.99
Cell death: the significance of apoptosis. Int Rev Cytol (1980) 24.88
The staphylococcal enterotoxins and their relatives. Science (1990) 11.99
The human immunodeficiency virus: infectivity and mechanisms of pathogenesis. Science (1988) 11.05
Detection of lymphocytes expressing human T-lymphotropic virus type III in lymph nodes and peripheral blood from infected individuals by in situ hybridization. Proc Natl Acad Sci U S A (1986) 8.06
The reservoir for HIV-1 in human peripheral blood is a T cell that maintains expression of CD4. Science (1989) 7.90
Regulation of lymphokine messenger RNA stability by a surface-mediated T cell activation pathway. Science (1989) 7.78
Antibodies to CD3/T-cell receptor complex induce death by apoptosis in immature T cells in thymic cultures. Nature (1989) 6.70
Qualitative analysis of immune function in patients with the acquired immunodeficiency syndrome. Evidence for a selective defect in soluble antigen recognition. N Engl J Med (1985) 6.46
Regulation of interleukin-2 gene enhancer activity by the T cell accessory molecule CD28. Science (1991) 5.12
Preferential infection of CD4+ memory T cells by human immunodeficiency virus type 1: evidence for a role in the selective T-cell functional defects observed in infected individuals. Proc Natl Acad Sci U S A (1990) 4.80
Detection of three distinct patterns of T helper cell dysfunction in asymptomatic, human immunodeficiency virus-seropositive patients. Independence of CD4+ cell numbers and clinical staging. J Clin Invest (1989) 3.92
Cell dysfunction and depletion in AIDS: the programmed cell death hypothesis. Immunol Today (1991) 3.79
The role of the T cell receptor in positive and negative selection of developing T cells. Science (1990) 3.64
Immunological abnormalities in human immunodeficiency virus (HIV)-infected asymptomatic homosexual men. HIV affects the immune system before CD4+ T helper cell depletion occurs. J Clin Invest (1988) 3.59
A superantigen encoded in the open reading frame of the 3' long terminal repeat of mouse mammary tumour virus. Nature (1991) 3.47
Interferon gamma plays a critical role in induced cell death of effector T cell: a possible third mechanism of self-tolerance. J Exp Med (1990) 3.45
Cyclosporin A inhibits activation-induced cell death in T-cell hybridomas and thymocytes. Nature (1989) 3.23
Death of mature T cells by separate ligation of CD4 and the T-cell receptor for antigen. Nature (1990) 2.73
Cellular signalling in programmed cell death (apoptosis). Immunol Today (1990) 2.64
Functional and phenotypic evidence for a selective loss of memory T cells in asymptomatic human immunodeficiency virus-infected men. J Clin Invest (1990) 2.51
Inhibition of antigen-induced lymphocyte proliferation by Tat protein from HIV-1. Science (1989) 2.44
CD44 contributes to T cell activation. J Immunol (1989) 2.44
A model for the selective loss of major histocompatibility complex self-restricted T cell immune responses during the development of acquired immune deficiency syndrome (AIDS). J Immunol (1986) 2.31
Evidence that T cell activation is required for HIV-1 entry in CD4+ lymphocytes. J Immunol (1989) 2.13
Few infected CD4+ T cells but a high proportion of replication-competent provirus copies in asymptomatic human immunodeficiency virus type 1 infection. J Virol (1991) 2.05
Calcium-dependent killing of immature thymocytes by stimulation via the CD3/T cell receptor complex. J Immunol (1989) 1.98
The Mycoplasma arthritidis T-cell mitogen, MAM: a model superantigen. Immunol Today (1991) 1.86
Activation-driven T cell death. I. Requirements for de novo transcription and translation and association with genome fragmentation. J Immunol (1989) 1.85
Interleukin-2 production used to detect antigenic peptide recognition by T-helper lymphocytes from asymptomatic HIV-seropositive individuals. Nature (1989) 1.80
Common epitope in human immunodeficiency virus (HIV) I-GP41 and HLA class II elicits immunosuppressive autoantibodies capable of contributing to immune dysfunction in HIV I-infected individuals. J Clin Invest (1989) 1.77
HTLV-III large envelope protein (gp120) suppresses PHA-induced lymphocyte blastogenesis. J Immunol (1987) 1.69
AIDS pathogenesis: a dynamic interaction between HIV and the immune system. Immunol Today (1990) 1.60
Antigen-induced apoptosis in developing T cells: a mechanism for negative selection of the T cell receptor repertoire. Eur J Immunol (1989) 1.58
Suppressor effects and cyclic AMP accumulation by the CD29 molecule of CD4+ lymphocytes. Nature (1989) 1.46
Agents that elevate cAMP stimulate DNA fragmentation in thymocytes. J Immunol (1990) 1.36
Defective signal transduction--a common pathway for cellular dysfunction in HIV infection? Immunol Today (1990) 1.35
T cell receptor-mediated DNA fragmentation and cell death in T cell hybridomas. J Immunol (1990) 1.16
IL-2 protects against anti-CD3-induced cell death in human medullary thymocytes. J Immunol (1990) 1.08
[Demonstration of an engagement process towards cell death by apoptosis in lymphocytes of HIV infected patients]. C R Acad Sci III (1991) 1.06
Immunological studies in the acquired immunodeficiency syndrome. II. Active suppression or intrinsic defect--investigated by mixing AIDS cells with HLA-DR identical normal cells. Scand J Immunol (1986) 1.03
Distinct pathways of CD4 and CD8 cells induce rapid target DNA fragmentation. J Immunol (1991) 0.96
Cell dysfunction and depletion in AIDS: the programmed cell death hypothesis. Immunol Today (1991) 3.79
Treatment of hepatic hydatid disease with mebedazole: preliminary results in four cases. Br Med J (1977) 3.10
[Immunoenzymologic diagnosis of parasitic diseases. II. Quantitative immunoenzymology]. Lille Med (1976) 2.74
PML induces a novel caspase-independent death process. Nat Genet (1998) 2.66
Immunity after treatment of human schistosomiasis: association between IgE antibodies to adult worm antigens and resistance to reinfection. Eur J Immunol (1992) 2.33
YOPRO-1 permits cytofluorometric analysis of programmed cell death (apoptosis) without interfering with cell viability. J Immunol Methods (1995) 2.25
Programmed cell death and AIDS: significance of T-cell apoptosis in pathogenic and nonpathogenic primate lentiviral infections. Proc Natl Acad Sci U S A (1994) 2.21
Specific IgE antibodies in immune adherence of normal macrophages to Schistosoma mansoni schistosomules. Nature (1975) 2.19
Heterogeneity of human peripheral blood eosinophils: variability in cell density and cytotoxic ability in relation to the level and the origin of hypereosinophilia. Int Arch Allergy Appl Immunol (1983) 2.17
A new function for platelets: IgE-dependent killing of schistosomes. Nature (1983) 2.11
Release of prostaglandin D2 into human airways during acute antigen challenge. N Engl J Med (1986) 2.03
Interleukin 5 synthesis by eosinophils: association with granules and immunoglobulin-dependent secretion. J Exp Med (1994) 2.01
In vitro evaluation of activities of nitazoxanide and tizoxanide against anaerobes and aerobic organisms. Antimicrob Agents Chemother (1996) 1.96
High-affinity IgE receptor on eosinophils is involved in defence against parasites. Nature (1994) 1.95
Ligand binding was acquired during evolution of nuclear receptors. Proc Natl Acad Sci U S A (1997) 1.94
On the evolution of programmed cell death: apoptosis of the unicellular eukaryote Leishmania major involves cysteine proteinase activation and mitochondrion permeabilization. Cell Death Differ (2002) 1.90
Interleukin 5 messenger RNA expression by eosinophils in the intestinal mucosa of patients with coeliac disease. J Exp Med (1992) 1.88
Role of IgE receptors in effector function of human eosinophils. J Immunol (1984) 1.87
Role of the parasite-derived prostaglandin D2 in the inhibition of epidermal Langerhans cell migration during schistosomiasis infection. J Exp Med (2001) 1.79
Reduction of atherosclerosis in apolipoprotein E knockout mice by activation of the retinoid X receptor. Proc Natl Acad Sci U S A (2001) 1.74
Molecular crosstalk in host-parasite relationships: schistosome- and leech-host interactions. Parasitol Today (2000) 1.73
Molecular characterization of a 23-kilodalton major antigen secreted by Toxoplasma gondii. Proc Natl Acad Sci U S A (1989) 1.73
Adenovirus type 2 assembly analyzed by reversible cross-linking of labile intermediates. J Virol (1978) 1.72
IgA antibodies against P30 as markers of congenital and acute toxoplasmosis. Lancet (1988) 1.70
Programmed cell death in mature erythrocytes: a model for investigating death effector pathways operating in the absence of mitochondria. Cell Death Differ (2001) 1.69
Serodiagnosis of toxoplasma infection using a purified parasite protein (P30). Clin Exp Immunol (1985) 1.64
A new function for the LDL receptor: transcytosis of LDL across the blood-brain barrier. J Cell Biol (1997) 1.64
The orphan nuclear receptor ROR alpha is a negative regulator of the inflammatory response. EMBO Rep (2001) 1.64
Fc receptors for IgE on human and rat eosinophils. J Immunol (1981) 1.63
Cellular and molecular mechanisms of senescent erythrocyte phagocytosis by macrophages. A review. Biochimie (1998) 1.62
Evidence for IgE-dependent cytotoxicity by rat eosinophils. J Immunol (1981) 1.61
The glutathione transferase activity and tissue distribution of a cloned Mr28K protective antigen of Schistosoma mansoni. EMBO J (1988) 1.55
ICBP90 belongs to a new family of proteins with an expression that is deregulated in cancer cells. Br J Cancer (2003) 1.53
Schistosoma mansoni schistosomula reduce E-selectin and VCAM-1 expression in TNF-alpha-stimulated lung microvascular endothelial cells by interfering with the NF-kappaB pathway. Eur J Immunol (1999) 1.49
Molecular cloning of a protective antigen of schistosomes. Nature (1987) 1.49
Interaction between IgE complexes and macrophages in the rat: a new mechanism of macrophage activation. Eur J Immunol (1977) 1.48
Analysis of the Mycobacterium tuberculosis 85A antigen promoter region. J Bacteriol (1995) 1.48
Quantitative determination of specific IgE antibodies to Echinococcus granulosus and IgE levels in sera from patients with hydatid disease. Immunology (1975) 1.47
Increased secretion of tumor necrosis factor alpha and interleukin-6 by alveolar macrophages consecutive to the development of the late asthmatic reaction. J Allergy Clin Immunol (1991) 1.46
[Antigenic structure of helminthes. Immunological aspects of the host-parasite relationship]. Pathol Biol (1968) 1.45
Involvement of immunoglobulin E in the secretory processes of alveolar macrophages from asthmatic patients. J Clin Invest (1983) 1.44
Enzyme release and superoxide anion production by human alveolar macrophages stimulated with immunoglobulin E. Clin Exp Immunol (1980) 1.42
Receptor for IgG(Fc) and human beta2-microglobulin on S. mansoni schistosomula. Nature (1979) 1.41
Schistosomiasis co-infection in humans influences inflammatory markers in uncomplicated Plasmodium falciparum malaria. Parasite Immunol (2005) 1.40
A purified 28,000 dalton protein from Schistosoma mansoni adult worms protects rats and mice against experimental schistosomiasis. J Immunol (1987) 1.39
Functional role of human IgG subclasses in eosinophil-mediated killing of schistosomula of Schistosoma mansoni. J Immunol (1989) 1.39
Fibronectin receptors on Trypanosoma cruzi trypomastigotes and their biological function. Nature (1984) 1.38
[Hantavirus infection without renal involvement]. Rev Med Interne (1994) 1.38
Major role of BAX in apoptosis during retinal development and in establishment of a functional postnatal retina. Dev Dyn (2003) 1.38
[Eosinophils and pathology of the digestive tract]. Gastroenterol Clin Biol (1990) 1.38
CD3-mediated apoptosis of human medullary thymocytes and activated peripheral T cells: respective roles of interleukin-1, interleukin-2, interferon-gamma and accessory cells. Eur J Immunol (1993) 1.36
[Immunologic diagnosis of human echinococcosis. (Personal report apropos of 400 cases)]. Pathol Biol (Paris) (1970) 1.36
Cytophilic binding of IgE to the macrophage. II. Immunologic release of lysosomal enzyme from macrophages by IgE and anti-IgE in the rat: a new mechanism of macrophage activation. Cell Immunol (1979) 1.36
Production of tumour necrosis factor-alpha (TNF-alpha) and interleukin-1 (IL-1) in patients with AIDS. Enhanced level of TNF-alpha is related to a higher cytotoxic activity. Clin Exp Immunol (1989) 1.35
Eosinophil-dependent cytotoxicity in rat schistosomiasis. Involvement of IgG2a antibody and role of mast cells. Eur J Immunol (1978) 1.33
The receptor for IgE on blood platelets. Eur J Immunol (1986) 1.32
Toxoplasma gondii: characterization and localization of antigens secreted from tachyzoites. Exp Parasitol (1990) 1.32
IgA antibodies to a protective antigen in human Schistosomiasis mansoni. J Immunol (1993) 1.30
Common cis-acting elements critical for the expression of several genes of Toxoplasma gondii. Mol Microbiol (1996) 1.30
Eosinophilic gastroenteritis: ultrastructural evidence for a selective release of eosinophil major basic protein. Clin Exp Immunol (1988) 1.29
Heterogeneity of human eosinophils. II. Variability of respiratory burst activity related to cell density. Clin Exp Immunol (1984) 1.28
Cytotoxicity of human and baboon mononuclear phagocytes against schistosomula in vitro: induction by immune complexes containing IgE and Schistosoma mansoni antigens. Clin Exp Immunol (1978) 1.26
Early neutrophil alveolitis after antigen inhalation in hypersensitivity pneumonitis. Chest (1985) 1.25
Molecular cloning of a novel widely expressed human 80 kDa 17 beta-hydroxysteroid dehydrogenase IV. Biochem J (1995) 1.24
Inhibition of lymphocyte proliferation by factor(s) produced by Schistosoma mansoni. Eur J Immunol (1977) 1.24
Macrophage triggering by aggregated immunoglobulins. I. Delayed effect of IgG aggregates or immune complexes. J Immunol (1981) 1.24
Evaluation of the enzyme-linked immunosorbent assay (ELISA) and other serological tests for the diagnosis of toxoplasmosis. Bull World Health Organ (1980) 1.23
Cytophilic binding of IgE to the macrophage. I. Binding characteristics of IgE on the surface of macrophages in the rat. Cell Immunol (1979) 1.23
Symptomatic hyperlactataemia: an emerging complication of antiretroviral therapy. AIDS (2000) 1.23
Immunoglobulin E and effector cells in schistosomiasis. Science (1994) 1.22
Is PCR a useful tool for the diagnosis of tuberculosis in 1995? Tuber Lung Dis (1995) 1.22
Subgenomic mRNA in OK10 defective leukemia virus-transformed cells. J Virol (1982) 1.22
Expression of CD28 and CD86 by human eosinophils and role in the secretion of type 1 cytokines (interleukin 2 and interferon gamma): inhibition by immunoglobulin a complexes. J Exp Med (1999) 1.22
Molecular characterization of a dense granule antigen (Gra 2) associated with the network of the parasitophorous vacuole in Toxoplasma gondii. Mol Biochem Parasitol (1993) 1.22
Circulating immune complexes in schistosomiasis. Immunology (1977) 1.20
Major surface protein of Toxoplasma gondii (p30) contains an immunodominant region with repetitive epitopes. Eur J Immunol (1985) 1.20
Similarities between the primary structures of two distinct major surface proteins of Toxoplasma gondii. J Biol Chem (1994) 1.20
In vitro and in vivo effector function of rat IgG2a monoclonal anti-S. mansoni antibodies. J Immunol (1982) 1.19
Rat mast cell-eosinophil interaction in antibody-dependent eosinophil cytotoxicity to Schistosoma mansoni schistosomula. J Immunol (1978) 1.19
Cytophilic IgE on human blood and tissue eosinophils: detection by flow microfluorometry. J Immunol (1985) 1.18
Dipetalonema viteae in hamsters: effect of antiserum or immunization with parasite extracts on production of microfilariae. Parasitology (1978) 1.18
Arsenic-interferon-alpha-triggered apoptosis in HTLV-I transformed cells is associated with tax down-regulation and reversal of NF-kappa B activation. Blood (2000) 1.18
Construction, expression, and immunogenicity of the Schistosoma mansoni P28 glutathione S-transferase as a genetic fusion to tetanus toxin fragment C in a live Aro attenuated vaccine strain of Salmonella. Proc Natl Acad Sci U S A (1994) 1.16
Tumor necrosis factor alpha and interleukin-6 production by human mononuclear phagocytes from allergic asthmatics after IgE-dependent stimulation. Am Rev Respir Dis (1992) 1.16
Trypanosoma cruzi infection inhibited by peptides modeled from a fibronectin cell attachment domain. Science (1986) 1.15
Recognition of Toxoplasma gondii excreted and secreted antigens by human sera from acquired and congenital toxoplasmosis: identification of markers of acute and chronic infection. Clin Exp Immunol (1988) 1.15
Incidence of primary opportunistic infections in two human immunodeficiency virus-infected French clinical cohorts. Int J Epidemiol (2001) 1.15